Springvest Valuation Multiples

Springvest is valued at $52M as of October 2026, a 7.5x revenue multiple. In the last 12 months, Springvest revenue was $7M and Springvest EBITDA was $1M.

Springvest Overview

About Springvest

Springvest Oyj is engaged in investing in unlisted growth companies which were only possible for angel and venture capitalists investing large sums.


Founded

2012

HQ

Finland

Employees

13

Financials (LTM)

Revenue: $7M
EBITDA: $1M

EV

$52M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Springvest Financials

Springvest reported last 12-month revenue of $7M and EBITDA of $1M.

In the same LTM period, Springvest generated $1M in EBITDA and $755K in net income.

Revenue (LTM)


Springvest P&L

In the most recent fiscal year, Springvest reported revenue of $7M and EBITDA of $1M.

Springvest is profitable as of last fiscal year, with gross margin of 56%, EBITDA margin of 21%, and net margin of 16%.

See analyst estimates for Springvest
LTMLast FY202320242025202620272028
Revenue$7M$7M$4M$8M$7M
Gross Profit-$4M$2M$5M$4M
Gross Margin-56%53%59%56%
EBITDA$1M$1M$657K$2M$1M
EBITDA Margin14%21%15%29%21%
EBIT Margin14%20%15%29%20%
Net Profit$755K$1M$421K$2M$1M
Net Margin11%16%10%24%16%

Financial data powered by Morningstar, Inc.

Springvest Stock Performance

Springvest has current market cap of $52M, and enterprise value of $52M.

Market Cap Evolution


Springvest's stock price is $9.32.

Springvest share price increased by 0.7% in the last 30 days, and by 15.2% in the last year.

Springvest has an EPS (earnings per share) of $0.19.

See more trading valuation data for Springvest
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$52M$52M0.2%0.7%13.1%15.2%$0.19

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Springvest Valuation Multiples

Springvest trades at 7.5x EV/Revenue multiple, and 52.3x EV/EBITDA.

See NTM and 2027E valuation multiples for Springvest

EV / Revenue (LTM)


Springvest Financial Valuation Multiples

As of October 17, 2026, Springvest has market cap of $52M and EV of $52M.

Springvest has a P/E ratio of 69.5x.

LTMLast FY202320242025202620272028
EV/Revenue7.5x8.0x12.0x6.5x8.0x
EV/EBITDA52.3x38.7x79.9x22.1x38.7x
EV/EBIT52.3x39.0x81.5x22.2x39.0x
EV/Gross Profit-14.4x22.7x11.1x14.4x
P/E69.5x50.1x124.8x27.7x50.1x
EV/FCF27.7xn/m183.9x23.1xn/m

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Springvest Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Springvest Margins & Growth Rates

Springvest grew revenue by 6% but EBITDA decreased by 34% in the last fiscal year.

In the most recent fiscal year, Springvest reported gross margin of 56%, EBITDA margin of 21%, and net margin of 16%.

See estimated margins and future growth rates for Springvest

Springvest Margins

Last FY202420252026202720282029
Gross Margin56%59%56%-
EBITDA Margin21%29%21%13%
EBIT Margin20%29%20%13%
Net Margin16%24%16%10%
FCF Margin(2%)28%(2%)10%

Springvest Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth6%84%(18%)6%
Gross Profit Growth-105%(23%)-
EBITDA Growth(34%)261%(43%)(34%)
EBIT Growth(33%)267%(43%)(33%)
Net Profit Growth(36%)350%(45%)(36%)
FCF Growth(613%)696%(106%)(613%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Springvest Operational KPIs

Springvest's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.2M for the same period.

Springvest's Rule of 40 is 19% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Springvest's Rule of X is 29% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Springvest
LTMLast FY202320242025202620272028
Rule of 4019%19%---
Bessemer Rule of X25%29%---
Revenue per Employee-$0.5M---
Opex per Employee-$0.2M---
S&M Expenses to Revenue-10%7%7%10%
G&A Expenses to Revenue-20%24%18%20%
Opex to Revenue-35%38%29%35%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Springvest Competitors

Springvest competitors include H-Farm, Acorn Capital Inv Fd, OFS Capital, OFS Credit, Sol Strategies, Ram-On Investments, PEARL DIVER CREDIT, Y/Knot Invest, Seafire and Cube Labs.

Most Springvest public comparables operate across Asset Management.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
H-Farm$43M$43M1.2x-1.2x-
Acorn Capital Inv Fd$7M-7.0x---
OFS Capital($4M)-(58.5x)7.2x--
OFS Credit$12M-11.9x3.7x--
Sol Strategies$10M($22M)8.8x(12.4x)(4.0x)-
Ram-On Investments------
PEARL DIVER CREDIT($9M)-(9.8x)---
Y/Knot Invest$16M($2M)5.2x-(35.0x)-

This data is available for Pro users. Sign up to see all Springvest competitors and their valuation data.

Start Free Trial

Investments by Springvest

Springvest has invested in 48 companies to date.

Latest investment by Springvest was on October 12th 2026. Springvest invested in Desentum in their $31M Undisclosed stage round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by Springvest

Desentum
Cerenion
Desentum
Basemark
Description
Desentum is a Helsinki-based biopharmaceutical firm developing allergy vaccines that induce immune tolerance to common allergens. The company targets hay fever, pet dander, and house dust mite reactions using molecular mechanisms to redesign antigens for long-term symptom relief. Desentum advances clinical candidates through partnerships with European research institutes.
Cerenion is a Helsinki-based medical technology company that develops C-Trend, a patented AI platform for real-time EEG analysis in emergency and intensive care units. C-Trend automates brain function monitoring for patients with stroke, cardiac arrest, or seizures, providing neurologist-grade assessments within minutes using standard EEG equipment. CE-marked since 2021, the system integrates with hospital monitors from Philips and Masimo across Europe and the United States.
Desentum is a Helsinki-based biopharmaceutical firm developing allergy vaccines that induce immune tolerance to common allergens. The company targets hay fever, pet dander, and house dust mite reactions using molecular mechanisms to redesign antigens for long-term symptom relief. Desentum advances clinical candidates through partnerships with European research institutes.
Basemark is a Tampere-headquartered provider of augmented reality software for automotive applications. The company supplies AR development tools for HUD navigation, ADAS visualization, and instrument clusters to OEMs like BMW and suppliers. Basemark's suite supports testing and deployment of AR features in production vehicles across Europe and Asia.
HQ CountryFinlandFinlandFinlandFinland
HQ City
Espoo
Oulu
Espoo
Helsinki
Deal Date12 Oct 20265 May 202627 Apr 202615 Jan 2026
RoundUndisclosed stageUndisclosed stageUndisclosed stageUndisclosed stage
Raised$31M$6M$21M$8M
InvestorsSpringvestSpringvestSpringvestSpringvest
Valuationundisclosedundisclosedundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Springvest investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Springvest

When was Springvest founded?Springvest was founded in 2012.
Where is Springvest headquartered?Springvest is headquartered in Finland.
How many employees does Springvest have?As of today, Springvest has over 13 employees.
Is Springvest publicly listed?Yes, Springvest is a public company listed on Nasdaq Helsinki.
What is the stock symbol of Springvest?Springvest trades under SPRING ticker.
When did Springvest go public?Springvest went public in 2021.
Who are competitors of Springvest?Springvest main competitors include H-Farm, Acorn Capital Inv Fd, OFS Capital, OFS Credit, Sol Strategies, Ram-On Investments, PEARL DIVER CREDIT, Y/Knot Invest, Seafire, Cube Labs.
What is the current market cap of Springvest?Springvest's current market cap is $52M.
What is the current revenue of Springvest?Springvest's last 12 months revenue is $7M.
What is the current revenue growth of Springvest?Springvest revenue growth (NTM/LTM) is 4%.
What is the current EV/Revenue multiple of Springvest?Current revenue multiple of Springvest is 7.5x.
What is the current EBITDA of Springvest?Springvest's last 12 months EBITDA is $1M.
What is Springvest's EBITDA margin?Springvest's last 12 months EBITDA margin is 14%.
What is the current EV/EBITDA multiple of Springvest?Current EBITDA multiple of Springvest is 52.3x.
What is the current FCF of Springvest?Springvest's last 12 months FCF is $2M.
What is Springvest's FCF margin?Springvest's last 12 months FCF margin is 27%.
What is the current EV/FCF multiple of Springvest?Current FCF multiple of Springvest is 27.7x.
How many companies Springvest has acquired to date?Springvest hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Springvest has invested to date?As of October 2026, Springvest has invested in 48 companies.
What was the last Springvest investment?On 12th October 2026 Springvest invested in Desentum, participating in a $31M Undisclosed stage round.
In what companies Springvest invested in?Springvest invested in ReOrbit, Desentum, Volare, Kuva Space, Verto Analytics, Norsepower Oy, Varjo, Solar Foods, Bioretec, Dispelix, Basemark, CurifyLabs, Sartar Therapeutics, Sulapac, Cerenion, Rocsole, Pesmel, NewIcon, Optitune, Mobidiag, and 28 other companies.

See public comps similar to Springvest

Lists including Springvest

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial